Jonathan R. Anolik, MD, FACP, FACE, Professor of Clinical Medicine at the Lewis Katz School of Medicine at Temple University, provided perspective to HealthCentral on a new study published in the New England Journal of Medicine showing promise for a possible cure for T1D using manufactured stem cells.